p16INK4A P81L [cytosol]

Stable Identifier
R-HSA-9632280
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
CDKN2A P81L, CDKN2A Pro81Leu, p16INK4A Pro81Leu
p16INK4A P81L [cytosol] icon
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
10389768 Functional reassessment of P16 variants using a transfection-based assay

Gabrielli, BG, Castellano, M, Walker, GJ, Hayward, NK

Int. J. Cancer 1999
External Reference Information
External Reference
Gene Names
CDKN2A, CDKN2, MLM, MTS1
Chain
chain:1-156
Other Identifiers
1029
11718293_a_at
1713_s_at
207039_PM_at
207039_at
209644_PM_x_at
209644_x_at
211156_PM_at
211156_at
3201444
3201445
3201446
3201447
3201448
3201450
3201451
3201457
3201458
3201459
3201460
3201461
3201464
3201465
3201466
3201467
3201477
3201478
3201483
3201485
73132_r_at
8160441
A_23_P43484
A_23_P43490
A_33_P3411628
GE59038
GO:0000278
GO:0001953
GO:0003723
GO:0004861
GO:0005515
GO:0005634
GO:0005694
GO:0005737
GO:0005829
GO:0006351
GO:0006355
GO:0007049
GO:0007155
GO:0007265
GO:0008285
GO:0012501
GO:0019901
GO:0023052
GO:0030308
GO:0032088
GO:0034393
GO:0035985
GO:0036211
GO:0042326
GO:0043226
GO:0045736
GO:0045892
GO:0051059
GO:0051726
GO:0090398
GO:0090399
GO:0098772
GO:2000045
GO:2000111
HMNXSV003019577
ILMN_1717714
ILMN_1757255
PH_hs_0019731
U26727_at
g1353569_3p_a_at
g1353569_3p_x_at
g4206166_3p_a_at
g4502748_3p_at
Participates
Other forms of this molecule
Modified Residues
Name
L-proline 81 replaced with L-leucine
Coordinate
81
PsiMod
A protein modification that effectively converts a source amino acid residue to an L-leucine.
A protein modification that effectively removes or replaces an L-proline.
Disease
Name Identifier Synonyms
hepatocellular carcinoma DOID:684 adult Hepatoma, adult primary Liver carcinoma, Liver carcinoma, Hepatocellular carcinoma (morphologic abnormality), primary carcinoma of liver (disorder), hepatoma, Hepatoma, adult primary hepatocellular carcinoma, primary carcinoma of the liver cells, Hepatocellular carcinoma (clinical), Liver carcinoma, HCC, carcinoma of liver, specified as primary
melanoma DOID:1909 Naevocarcinoma, melanoma, melanoma, malignant melanoma, morphology (morphologic abnormality), malignant melanoma NOS (morphologic abnormality), malignant melanoma (disorder), malignant melanoma, malignant melanoma, malignant melanoma, malignant melanoma
thyroid carcinoma DOID:3963 head and neck cancer, Thyroid
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
breast cancer DOID:1612 malignant tumor of the breast, mammary cancer, malignant neoplasm of breast, mammary tumor, primary breast cancer, breast cancer, Ca breast - NOS, breast tumor
basal cell carcinoma DOID:2513 malignant Basal cell neoplasm, malignant basal cell tumor, malignant basal cell tumor (morphologic abnormality), Basal cell cancer, BASAL CELL carcinoma OF SKIN, Rodent ulcer, Rodent ulcer, Basal cell carcinoma NOS (morphologic abnormality), Basal cell neoplasm NOS (morphologic abnormality), Rodent ulcer, basal cell carcinoma, Basal cell carcinoma (morphologic abnormality), Epithelioma basal cell (disorder), basal cell neoplasm, Basal cell neoplasm (morphologic abnormality), Basal cell tumor (morphologic abnormality), Rodent ulcer, Basal cell carcinoma of skin (disorder), Basal cell tumor
skin squamous cell carcinoma DOID:3151 Epidermoid skin carcinoma, squamous cell carcinoma of skin (disorder)
pancreatic ductal adenocarcinoma DOID:3498 ductal adenocarcinoma of the pancreas
larynx cancer DOID:2596
pharynx squamous cell carcinoma DOID:0050921
Interactors (12)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P11802 CDK4  3 0.96 19
 UniProt:Q00534 CDK6  3 0.949 19
 UniProt:P12004 PCNA  5 0.61 8
 UniProt:P02730 SLC4A1  8 0.602 5
 UniProt:O75496 GMNN  2 0.592 2
 UniProt:Q6UXH1 CREL2      0.508 2
 UniProt:Q00839 HNRNPU  1 0.508 2
 UniProt:Q8NHU6 TDRD7      0.508 2
 UniProt:O75398 DEAF1      0.508 2
 UniProt:Q14566 MCM6  1 0.499 4
 UniProt:P24385 CCND1  4 0.491 2
 UniProt:P62826 RAN  2 0.463 2
Cite Us!